Effect of Low Level Laser Therapy and Pelvic Stabilisation Exercises on Postpartum Pelvic Girdle Pain
PGP
Effect of Low-level Laser Therapy and Pelvic Stabilisation Exercises on Postpartum Pelvic Girdle Pain
1 other identifier
interventional
90
1 country
2
Brief Summary
This study will be conducted to show the effect of low level laser therapy 810 nm and pelvic stabilization exercises has Effect on pelvic girdle pain Postpartum Pelvic girdle pain (PPGP) is common complaint in pregnant women all over the world and it has a major impact on health and functioning as it decreases quality of life. PGP generally arises in relation with pregnancy, trauma and reactive arthritis. The onset of PGP is usually by weeks 17-19 of gestation, with a peak of incidence by weeks 24- 36. Postpartum follow-up studies have shown that 5- 27% of the women had persisting pain 1-3 months after delivery. However, it was report that 7% have remaining pain 6 years after delivery causing severe discomfort and reduced ability to work , ninety prime-gravid or multigravida postnatal women's were randomly classified into three groups, Group (A): composed of 30 patients who received low-level laser therapy and pelvic stabilization exercises for 12 sessions over six week's period by 2 sessions per week. Group (B): composed of 30 patients who low-level laser therapy only for 12 sessions over six week's period by 2 sessions per week and Group (C): composed of 30 patients who received pelvic stabilization exercises For 12 sessions over six week's period by 2 sessions per week. Pain Using Visual analogue scale, serum cortisol level, and disability using pelvic girdle questionnaire) were measured and compared at 0 and 6 weeks after the treatment in the 3 groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2018
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
July 14, 2018
CompletedFirst Posted
Study publicly available on registry
July 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2021
CompletedDecember 10, 2020
December 1, 2020
3.2 years
July 14, 2018
December 8, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Pain intensity:
Pain will assessed by using VAS that is a 10 mm calibrated line with zero representing no pain and10 representing worst pain using Visual analogue scale"VAS" that is a 10 mm calibrated line with zero representing no pain and 10 representing worst pain.Worst during the past week Change from baseline to follow-up
Baseline to 6 weeks after treatment .
Pelvic Girdle Questionnaire
The Pelvic Girdle Questionnaire (PG Q) is a condition-specific measure for women with pelvic girdle pain (PGP). The questionnaire has 25 items under two sub-scales (20 items for activates and 5 items for symptoms), with percentage scores that range from 0 (no disability) to 100 (great disability),thus supplying a gap in research and clinical practice. The PG Q includes items relating to activity/participation and bodily symptoms and has reliability, validity, and feasibility for use in research and clinical practice.
Baseline to 6 weeks after treatment
Serum cortisol level:
Cortisol is a hormone secreted by the adrenal gland. It is the major corticosteroids. It is responsible for about 95% of all glucocorticoids activity in the body.(Pool and Axford 2001) It released into our body when we are under stress. Cortisol is high in subjects suffering from pain as compared with healthy and pain free subjects, as there is positive correction between the intensity of pain and increased plasma cortisol level. The blood sample will take for the measurement of plasma cortisol from 9 a.m. to 1 p.m. Each patient will be drawn two 5 ml blood samples from cubital vein two time
Baseline to 6 weeks after treatment
Secondary Outcomes (2)
FABER Test (Patrick's test)
Baseline to 6 weeks after treatment
Posterior pelvic pain provocation test (PPPPT)
Baseline to 6 weeks after treatment .
Study Arms (3)
group(A) low level laser therapy
EXPERIMENTALcomposed of 30 patients who received pelvic stabilization exercises and low level laser therapy For 12 sessions over six week's period by 2 sessions per week.
group(B) pelvic stabilization exercises only
ACTIVE COMPARATORcomposed of 30 patients who pelvic stabilization exercises only For 12 sessions over six week's period by 2 sessions per week.
group (C) low level laser therapy only
ACTIVE COMPARATORcomposed of 30 patients who low level laser therapy only For 12 sessions over six week's period by 2 sessions per week.
Interventions
low level laser therapy (LLLT) is a modality that has been used by the medical profession for decades to treat acute and chronic pain conditions ranging from tendonitis and bursitis, to back pain and pelvic girdle pain.
special program of pelvic stabilization exercises depending on exercising of transverse abdominal in addition to co activation of lumbar multifidus muscles at the lumbosacral area , exercising of oblique abdominal, gluteus maximus, latissimus dorsi muscles , quadratus lumborum, erector spinae, also, hip abductors and adductors. will done by all patients
Eligibility Criteria
You may qualify if:
- Ongoing sacral pain with onset during the preceding pregnancy reported on a present pain drawing
- Pain intensity ≥4 cm as worst during the past week on a 10 cm visual analogue scale (VAS)
- One positive pain provocation test of either Posterior Pelvic Pain Provocation test, Patrick's Faber test.
- Provoked pain by a gentle pressure on the ischial spine, ipsilateral to reported sacral pain, at least unilaterally.
You may not qualify if:
- Nerve root affection in the lumbo-sacral spine
- Inflammatory disease with pelvic bone and/or spinal manifestation
- Known endometriosis, gynecologic cancer or ongoing malign disease.
- Previous surgery of the lumbar spine.
- Incapacity to complete the questionnaires.
- Age \<18 years.
- Body mass index ≥35 kg/m2.
- Intolerance to the treatment dose or negative reactions of the laser treatment.
- A new pregnancy, during treatment or between the follow-ups. -
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (2)
Cairo university
Giza, Cairo Governorate, +02, Egypt
Cairo university
Giza, +02, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Adly A Sabbour, professor
Cairo University
- PRINCIPAL INVESTIGATOR
Mona I Morsy, professor
Cairo University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- If low level laser therapy 810nm and pelvic stabilization exercises can reduce pain and improve function there will be a new treatment option for this condition
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Physical Therapist department in Imbaba general hospital
Study Record Dates
First Submitted
July 14, 2018
First Posted
July 31, 2018
Study Start
May 1, 2018
Primary Completion
July 1, 2021
Study Completion
August 1, 2021
Last Updated
December 10, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
- Time Frame
- started on October 2018
- Access Criteria
- Purpose: Postpartum Pelvic girdle pain (PPGP) is common complaint in pregnant women all over the world and it has a major impact on health and functioning as it decreases quality of life. PGP generally arises in relation with pregnancy, trauma and reactive arthritis. The onset of PGP is usually by weeks 17-19 of gestation, with a peak of incidence by weeks 24- 36. Postpartum follow-up studies have shown that 5- 27% of the women had persisting pain 1-3 months after delivery. However, it was report that 7% have remaining pain 6 years after delivery causing severe discomfort and reduced ability to work
Methods: ninety prime-gravida or multigravida postnatal women's randomly classified into three groups, Group (A): composed of 30 patients who received pelvic stabilization exercises For 12 sessions over six week's period by 2 sessions per week. Group (B): composed of 30 patients who low-level laser therapy only for 12 sessions over six week's period by 2 sessions per week and Group(C): composed of 30 women's who received low-level laser therapy and pelvic stabilization exercises for 12 sessions over six week's period by 2 sessions per week. Pain Using Visual analogue scale, serum cortisol level, Faber test, PPPPT, and disability using pelvic girdle questionnaire were measured and compared at 0 and 6 weeks after the treatment in the 3 groups.